Fresh vs Frozen Embryo Transfer: Which One and Why

Your RE has suggested one option, and you are trying to figure out whether the suggestion is right for your body, your numbers, and your timeline. The fresh vs frozen embryo transfer choice is one of the most consequential decisions of the cycle, and the right answer depends on you, not on the average. This post walks through the evidence the way I would across a desk.

The freeze-all shift over the last decade was not driven by twin avoidance. It was driven by data showing that the post-stimulation uterine environment is suboptimal for implantation in many patients, that vitrification has matured, and that segmented cycles produce better outcomes in PCOS and high responders. That is the headline. The rest of the post is the texture under it.

Fresh vs frozen embryo transfer: what each means

The two options, in plain language:

• Fresh embryo transfer: Your embryo is placed back into the uterus on day 3 or day 5 after egg retrieval, in the same cycle as stimulation. The whole cycle, from baseline to beta, runs about six to eight weeks.
• Frozen embryo transfer (FET): All viable embryos are vitrified (flash-frozen) post-retrieval. Transfer happens in a separate prep cycle, typically four to eight weeks later, sometimes longer if your clinic wants you to recover from stimulation first. The frozen embryo transfer meaning, in practical terms, is splitting one IVF cycle into two appointments with a planned pause in between.
• Freeze-all (elective FET): Every embryo is frozen by clinic policy, with no fresh attempt. Increasingly common, especially in high responders and in any cycle using preimplantation genetic testing.

Why freeze-all has grown in 2014 to 2024

Several forces converged. Vitrification survival rates have crossed 95 percent at most modern labs, which means freezing an embryo no longer carries the implantation penalty that slow-freezing used to. Implantation rates per transfer are now comparable, and in several profiles favor frozen.

The bigger reason is what stimulation does to the uterus. Supraphysiologic estradiol and progesterone levels during ovarian stimulation can advance the endometrial lining relative to the embryo's developmental stage, creating a small but real mismatch in the implantation window. In a fresh cycle, the embryo arrives in a uterus that has been through six to twelve days of injected hormones. In a frozen cycle, the uterus is prepared from baseline, on its own timeline, weeks later.

OHSS (ovarian hyperstimulation syndrome) prevention is the third driver. In a fresh cycle, a positive pregnancy hCG can amplify late-onset OHSS in high responders. Freezing all embryos and transferring in a later cycle removes that risk almost entirely. PGT-A (preimplantation genetic testing for aneuploidy) is the fourth, since biopsy turnaround takes a week or more and embryos must be frozen while results pend.

Finally, some perinatal data favor FET in specific outcomes. The Maheshwari et al. cumulative meta-analysis found lower rates of preterm birth and low birthweight after frozen transfers, with a corresponding rise in large-for-gestational-age babies and a small increase in preeclampsia³. The magnitudes are small, and they should inform the conversation rather than dictate it.

The PCOS-specific argument, Chen et al. NEJM 2016

If you are reading this with PCOS, the landmark trial is Chen et al. 2016 in the New England Journal of Medicine. The researchers randomized 1,508 women with PCOS to fresh embryo transfer versus frozen embryo transfer. The results were clear. The FET arm achieved a 49.3 percent live birth rate compared with 42.0 percent in the fresh arm¹. The OHSS rate in the FET arm was dramatically lower, which matters because PCOS substantially raises OHSS risk.

That trial is why freeze-all has become close to the default for PCOS in most US clinics. I will say this plainly. For my PCOS patients, I almost always recommend freeze-all. The live-birth advantage is real, the OHSS risk reduction is meaningful, and the timeline cost (an extra four to eight weeks) is small relative to the cycle as a whole. For my average responders, the conversation is more open.

A separate point worth making: the Chen NEJM 2018 follow-up trial in ovulatory women without PCOS found equivalence between fresh and frozen single blastocyst transfer⁴. That trial is the reason fresh transfer is still a reasonable choice in non-PCOS, ovulatory, average-responder patients. The "freeze everyone, always" position is not what the data say.

Where fresh transfer still makes sense

Despite the freeze-all trend, fresh transfer remains the right call for several profiles. If you are an average responder without OHSS risk, get a euploid blastocyst on day 5, and want the fastest path to pregnancy, fresh is reasonable. If you are not planning PGT-A, fresh saves you a prep cycle. If you have a single blastocyst on day 5 and no other embryos to freeze, some clinics prefer to transfer fresh rather than risk a thaw failure on a solo embryo.

The Roque et al. 2019 meta-analysis pooled data across multiple trials and found, in non-PCOS populations, that fresh and elective frozen transfer produced similar live-birth rates per cycle². The pros and cons of fresh vs frozen embryo transfer therefore look different depending on whether your AMH is 1.5 or 6.0, whether you have PCOS, and whether you are doing PGT.

The fresh embryo transfer success rate vs frozen comparison is not a single number. It is a conditional probability that depends on your diagnosis, your response, your embryo cohort, and your clinic's lab quality. Ask your RE for clinic-specific numbers for someone with your profile, not the national average from the SART database.

The FET prep options

If freeze-all is the choice, the next decision is how to prepare the uterus for transfer. Three protocols, in rough order of medication burden:

1. Programmed FET (medicated, hormone replacement): Estradiol patches, oral tablets, or vaginal preparations start on cycle day 1 to 3 of the prep cycle. After two to three weeks of estrogen, when the lining looks ready, progesterone is added. The transfer is timed to the day of progesterone start: for a day-5 blastocyst, transfer happens on the sixth day of progesterone exposure. Highly schedulable, lots of medication, no ovulation required.
2. Natural FET: Your own ovulation is tracked with LH surge kits and ultrasound, progesterone is added after ovulation, and the transfer is timed five to six days post-ovulation for a blastocyst. Fewer medications, closer to physiology, harder to schedule, and dependent on ovulating reliably.
3. Modified natural FET: Letrozole or low-dose gonadotropins are used to support ovulation, often in patients who do not ovulate predictably (including some patients with PCOS), then progesterone is added off the trigger.

The Cochrane review on endometrial preparation for FET did not find a clear winner in terms of live birth⁵. The choice tends to be clinic-driven and history-driven, not evidence-mandated. If you have a reliable ovulatory cycle, many clinics will offer natural FET; if you do not, programmed is the default.

Perinatal outcome differences

This is where the conversation gets specific. The Maheshwari et al. cumulative meta-analysis suggested that FET pregnancies carry slightly higher rates of large-for-gestational-age babies, possibly higher preeclampsia risk, while fresh transfer pregnancies carry slightly higher rates of preterm birth and low birthweight³. These are real differences, statistically significant in pooled data, but the absolute magnitudes are small for any individual patient.

For most readers, these perinatal differences are not the deciding factor. The bigger question is which transfer type gives you the best live-birth probability per attempt for your profile. If FET adds one to two percentage points to your live-birth chance and the perinatal trade-off is a small shift in birthweight distribution, FET is usually still the better choice. If fresh and frozen are equivalent for your profile, the perinatal data may tip the decision.

Costs and timeline

The freeze-all path is not free. Some hard numbers, with the caveat that they vary widely by region and clinic.

• Fresh transfer: Usually bundled into the retrieval cycle price. No additional transfer fee.
• FET cycle: Adds roughly $3,000 to $6,000 per cycle in the US, covering monitoring, medications (estradiol, progesterone), the embryologist's thaw work, and the transfer itself.
• Storage fees: Often $500 to $1,000 per year after the first year, sometimes included in the first year as part of the retrieval bundle.
• Cumulative time: A freeze-all followed by a first FET adds roughly four to eight weeks compared with a fresh transfer.

If you have multiple embryos and plan to use them across more than one transfer attempt, storage and FET costs are already part of the budget. If you have one embryo and a fresh transfer is medically reasonable, the cost of moving to freeze-all is meaningful.

The 2024 to 2025 default, by patient profile

A rough map I share with patients in clinic:

• PCOS, or high responder (AMH > 3.5 ng/mL, AFC > 20): Freeze-all is standard. The Chen NEJM 2016 trial drives the recommendation, and OHSS prevention reinforces it.
• PGT-A planned: Freeze-all is required. Biopsy turnaround is one to two weeks, and embryos must be frozen while results pend.
• Average responder, no PGT, single euploid-looking blastocyst on day 5: Fresh transfer is reasonable and matches the Shi NEJM 2018 equivalence data.
• Older patients (over 40) with a limited embryo cohort: Discuss case by case. The trade-offs change with cohort size and clinic-specific data.

This is a starting frame, not a prescription. Your RE knows your history and your local lab quality. The conversation should produce a recommendation that fits your numbers, not a population average.

What to ask your RE

When you sit down for the protocol conversation, the questions worth asking:

• What is your default for someone with my AMH, AFC, and diagnosis?
• If we are freezing, what is the timeline from retrieval to first FET at your clinic?
• Will the FET be programmed or natural? Why?
• What is your clinic's vitrification survival rate?
• Does PGT-A push us to freeze regardless of my profile?
• What is my expected per-transfer live-birth rate with each approach?
• What is the cost difference between fresh and freeze-all, including storage?

I tell patients to write the answers down. Decisions made under fluorescent lights tend to blur on the drive home.

Fresh vs frozen embryo transfer: what this means for you

The fresh vs frozen embryo transfer question is not a single answer. For PCOS and high responders, freeze-all gives a meaningful live-birth advantage and a substantial OHSS-risk reduction. For average responders, the two are largely equivalent, with small perinatal differences and a meaningful timeline-and-cost difference. The decision should be made on your numbers, not on the trend.

Two practical takeaways. First, ask for clinic-specific data for your profile, not national averages. Second, if your RE recommends freeze-all and you have PCOS, the Chen NEJM 2016 trial is the reason. It is one of the most cited fertility trials of the last decade for a reason.

What's next

• If you are deciding how many embryos to transfer next, read single vs double embryo transfer.
• If you are heading into FET prep, read embryo transfer prep.
• If you want the larger map of the transfer cycle, return to the pillar: embryo transfer explained.
• If a prior transfer did not work and you are weighing the next step, read failed IVF, decoding the next step.

Sources

1. Chen ZJ, Shi Y, Sun Y, et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. New England Journal of Medicine 2016;375(6):523-533. https://doi.org/10.1056/NEJMoa1513873
2. Roque M, Haahr T, Geber S, Esteves SC, Humaidan P. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes. Human Reproduction Update 2019;25(1):2-14. https://doi.org/10.1093/humupd/dmy033
3. Maheshwari A, Pandey S, Amalraj Raja E, et al. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer? Human Reproduction Update 2018;24(1):35-58. https://doi.org/10.1093/humupd/dmx031
4. Shi Y, Sun Y, Hao C, et al. Transfer of fresh versus frozen embryos in ovulatory women. New England Journal of Medicine 2018;378(2):126-136. https://doi.org/10.1056/NEJMoa1705334
5. Practice Committee of the American Society for Reproductive Medicine. ASRM standard embryo transfer protocol template: a committee opinion. Fertility and Sterility 2017;107(4):897-900. https://doi.org/10.1016/j.fertnstert.2017.02.108
6. Mackens S, Santos-Ribeiro S, van de Vijver A, et al. Frozen embryo transfer: a review on the optimal endometrial preparation and timing. Human Reproduction 2017;32(11):2234-2242. https://doi.org/10.1093/humrep/dex285